David Shaw’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Sell
33,600
-48,400
-59% -$4.42M ﹤0.01% 2776
2026
Q1
$3.04M Sell
82,000
-289,900
-78% -$9.27M ﹤0.01% 2582
2025
Q4
$7.51M Buy
371,900
+6,300
+2% +$152K ﹤0.01% 1993
2025
Q3
$11M Buy
365,600
+270,600
+285% +$5.86M 0.01% 1602
2025
Q2
$1.23M Buy
95,000
+65,000
+217% +$619K ﹤0.01% 3094
2025
Q1
$219K Sell
30,000
-32,900
-52% -$364K ﹤0.01% 3901
2024
Q4
$1.05M Hold
62,900
﹤0.01% 3183
2024
Q3
$808K Hold
62,900
﹤0.01% 3416
2024
Q2
$703K Buy
62,900
+30,000
+91% +$350K ﹤0.01% 3411
2024
Q1
$408K Buy
+32,900
New +$548K ﹤0.01% 3585

Other funds holding AEHR

David Shaw's AEHR Position: Q2 2026 in Review

David Shaw increased its Aehr Test Systems (AEHR) stake by 245% in Q2 2026, buying an estimated $76.4M and bringing the position to 1,177,421 shares worth $113M. The position accounts for 0.05% of the portfolio, ranked #408.

David Shaw first reported a position in AEHR in Q1 2022 and has held it in 10 quarters since. 261 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • David Shaw held 1,177,421 shares of Aehr Test Systems worth $113M as of Q2 2026.
  • David Shaw bought 835,783 Aehr Test Systems shares in Q2 2026, an estimated $76.4M.
  • Aehr Test Systems made up 0.05% of David Shaw's portfolio in Q2 2026, its #408 holding.
  • David Shaw first reported a position in Aehr Test Systems in Q1 2022 and has held it in 10 quarters since.
  • 261 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.